Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

NCT02849873 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne

Interventions

DRUG: IDP-123 Lotion
DRUG: Tazorac Cream

Sponsor

Bausch Health Americas, Inc.